{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:41:24Z","timestamp":1791477684343,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Medical Health Science and Technology Project of Zhejiang Provincial Health Commission","award":["2018KY322"],"award-info":[{"award-number":["2018KY322"]}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Traditional Chinese Medicine Administration","doi-asserted-by":"publisher","award":["2016ZB004"],"award-info":[{"award-number":["2016ZB004"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Traditional Chinese Medicine Administration","doi-asserted-by":"publisher","award":["2019ZA024"],"award-info":[{"award-number":["2019ZA024"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Traditional Chinese Medicine Administration","doi-asserted-by":"publisher","award":["2020ZB056"],"award-info":[{"award-number":["2020ZB056"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ20H290002"],"award-info":[{"award-number":["LQ20H290002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00210-020-01914-1","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T22:02:32Z","timestamp":1591826552000},"page":"383-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Berberine attenuates non-alcoholic steatohepatitis by regulating chemerin\/CMKLR1 signalling pathway and Treg\/Th17 ratio"],"prefix":"10.1007","volume":"394","author":[{"given":"Zengsheng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengbin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9832-397X","authenticated-orcid":false,"given":"Liyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoxiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"1914_CR1","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.lpm.2019.09.051","volume":"48","author":"R Anty","year":"2019","unstructured":"Anty R, Gual P (2019) Pathogenesis of non-alcoholic fatty liver disease. Presse Med 48:1468\u20131483. https:\/\/doi.org\/10.1016\/j.lpm.2019.09.051","journal-title":"Presse Med"},{"key":"1914_CR2","doi-asserted-by":"publisher","unstructured":"Buechler C, Feder S, Haberl EM, Aslanidis C (2019) Chemerin isoforms and activity in obesity. Int J Mol Sci 20. https:\/\/doi.org\/10.3390\/ijms20051128","DOI":"10.3390\/ijms20051128"},{"key":"1914_CR3","unstructured":"Cao Y, Pan Q, Cai W, Shen F, Chen GY, Xu LM, Fan JG (2016) Modulation of gut microbiota by berberine improves steatohepatitis in high-fat diet-fed BALB\/C mice. Arch Iran Med 19:197\u2013203"},{"key":"1914_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12967-016-0982-x","volume":"14","author":"X Chang","year":"2016","unstructured":"Chang X, Wang Z, Zhang J, Yan H, Bian H, Xia M, Lin H, Jiang J, Gao X (2016) Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease. J Transl Med 14:266. https:\/\/doi.org\/10.1186\/s12967-016-0982-x","journal-title":"J Transl Med"},{"key":"1914_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-319-41334-1_2","volume":"928","author":"AF Cicero","year":"2016","unstructured":"Cicero AF, Baggioni A (2016) Berberine and its role in chronic disease. Adv Exp Med Biol 928:27\u201345. https:\/\/doi.org\/10.1007\/978-3-319-41334-1_2","journal-title":"Adv Exp Med Biol"},{"key":"1914_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/eje-13-0112","volume":"169","author":"S Docke","year":"2013","unstructured":"Docke S, Lock JF, Birkenfeld AL, Hoppe S, Lieske S, Rieger A, Raschzok N, Sauer IM, Florian S, Osterhoff MA, Heller R, Herrmann K, Lindenmuller S, Horn P, Bauer M, Weickert MO, Neuhaus P, Stockmann M, Mohlig M, Pfeiffer AF, von Loeffelholz C (2013) Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. Eur J Endocrinol 169:547\u2013557. https:\/\/doi.org\/10.1530\/eje-13-0112","journal-title":"Eur J Endocrinol"},{"key":"1914_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1210\/en.2011-1490","volume":"153","author":"MC Ernst","year":"2012","unstructured":"Ernst MC, Haidl ID, Zuniga LA, Dranse HJ, Rourke JL, Zabel BA, Butcher EC, Sinal CJ (2012) Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 153:672\u2013682. https:\/\/doi.org\/10.1210\/en.2011-1490","journal-title":"Endocrinology"},{"key":"1914_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","volume":"1061","author":"GC Farrell","year":"2018","unstructured":"Farrell GC, Haczeyni F, Chitturi S (2018) Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease. Adv Exp Med Biol 1061:19\u201344. https:\/\/doi.org\/10.1007\/978-981-10-8684-7_3","journal-title":"Adv Exp Med Biol"},{"key":"1914_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.22034\/iji.2019.80284","volume":"16","author":"A Hadinia","year":"2019","unstructured":"Hadinia A, Doustimotlagh AH, Goodarzi HR, Arya A, Jafarinia M (2019) Circulating levels of pro-inflammatory cytokines in patients with nonalcoholic fatty liver disease and non-alcoholic steatohepatitis. Iran J Immunol 16:327\u2013333. https:\/\/doi.org\/10.22034\/iji.2019.80284","journal-title":"Iran J Immunol"},{"key":"1914_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1124\/pr.116.013177","volume":"70","author":"AJ Kennedy","year":"2018","unstructured":"Kennedy AJ, Davenport AP (2018) International Union of Basic and Clinical Pharmacology CIII: Chemerin receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) nomenclature, pharmacology, and function. Pharmacol Rev 70:174\u2013196. https:\/\/doi.org\/10.1124\/pr.116.013177","journal-title":"Pharmacol Rev"},{"key":"1914_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yexmp.2013.07.009","volume":"95","author":"S Krautbauer","year":"2013","unstructured":"Krautbauer S, Wanninger J, Eisinger K, Hader Y, Beck M, Kopp A, Schmid A, Weiss TS, Dorn C, Buechler C (2013) Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Exp Mol Pathol 95:199\u2013205. https:\/\/doi.org\/10.1016\/j.yexmp.2013.07.009","journal-title":"Exp Mol Pathol"},{"key":"1914_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.plipres.2012.10.004","volume":"52","author":"AK Leamy","year":"2013","unstructured":"Leamy AK, Egnatchik RA, Young JD (2013) Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res 52:165\u2013174. https:\/\/doi.org\/10.1016\/j.plipres.2012.10.004","journal-title":"Prog Lipid Res"},{"key":"1914_CR13","doi-asserted-by":"publisher","first-page":"897914","DOI":"10.1155\/2015\/897914","volume":"2015","author":"J Li","year":"2015","unstructured":"Li J, Liu Z, Guo M (2015) Metabolomics profiling to investigate the pharmacologic mechanisms of berberine for the treatment of high-fat diet-induced nonalcoholic steatohepatitis. Evid Based Complement Alternat Med 2015:897914\u2013897919. https:\/\/doi.org\/10.1155\/2015\/897914","journal-title":"Evid Based Complement Alternat Med"},{"key":"1914_CR14","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/abbs\/gmy131","volume":"50","author":"J Liu","year":"2018","unstructured":"Liu J, Li W, Zhu W, He W, Zhao H, Xiang Y, Liu C, Wu W (2018a) Chronic intermittent hypoxia promotes the development of experimental non-alcoholic steatohepatitis by modulating Treg\/Th17 differentiation. Acta Biochim Biophys Sin 50:1200\u20131210. https:\/\/doi.org\/10.1093\/abbs\/gmy131","journal-title":"Acta Biochim Biophys Sin"},{"key":"1914_CR15","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/s41374-018-0074-z","volume":"98","author":"XJ Liu","year":"2018","unstructured":"Liu XJ, Duan NN, Liu C, Niu C, Liu XP, Wu J (2018b) Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water. Lab Investig 98:1184\u20131199. https:\/\/doi.org\/10.1038\/s41374-018-0074-z","journal-title":"Lab Investig"},{"key":"1914_CR16","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado MV, Diehl AM (2016) Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology 150:1769\u20131777. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.066","journal-title":"Gastroenterology"},{"key":"1914_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/07315724.2018.1504348","volume":"38","author":"S Mirmajidi","year":"2019","unstructured":"Mirmajidi S, Izadi A, Saghafi-Asl M, Vahid F (2019) Inflammatory potential of diet: association with chemerin, omentin, lipopolysaccharide-binding protein, and insulin resistance in the apparently healthy obese. J Am Coll Nutr 38:302\u2013310. https:\/\/doi.org\/10.1080\/07315724.2018.1504348","journal-title":"J Am Coll Nutr"},{"key":"1914_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11154-016-9339-2","volume":"17","author":"M Nati","year":"2016","unstructured":"Nati M, Haddad D, Birkenfeld AL, Koch CA, Chavakis T, Chatzigeorgiou A (2016) The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord 17:29\u201339. https:\/\/doi.org\/10.1007\/s11154-016-9339-2","journal-title":"Rev Endocr Metab Disord"},{"key":"1914_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/14656566.2018.1543403","volume":"20","author":"Y Ogawa","year":"2019","unstructured":"Ogawa Y, Yoneda M, Kobayashi T, Honda Y, Kessoku T, Imajo K, Saito S, Nakajima A (2019) Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults. Expert Opin Pharmacother 20:69\u201382. https:\/\/doi.org\/10.1080\/14656566.2018.1543403","journal-title":"Expert Opin Pharmacother"},{"key":"1914_CR20","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s12325-019-00960-3","volume":"36","author":"M Povsic","year":"2019","unstructured":"Povsic M, Wong OY, Perry R, Bottomley J (2019) A structured literature review of the epidemiology and disease burden of non-alcoholic steatohepatitis (NASH). Adv Ther 36:1574\u20131594. https:\/\/doi.org\/10.1007\/s12325-019-00960-3","journal-title":"Adv Ther"},{"key":"1914_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3978\/j.issn.2304-3881.2015.01.02","volume":"4","author":"P Ramadori","year":"2015","unstructured":"Ramadori P, Kroy D, Streetz KL (2015) Immunoregulation by lipids during the development of non-alcoholic steatohepatitis. Hepatobiliary Surg Nutr 4:11\u201323. https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2015.01.02","journal-title":"Hepatobiliary Surg Nutr"},{"key":"1914_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5604\/01.3001.0010.3795","volume":"71","author":"M Stojek","year":"2017","unstructured":"Stojek M (2017) The role of chemerin in human disease. Postepy Hig Med Dosw (Online) 71:110\u2013117. https:\/\/doi.org\/10.5604\/01.3001.0010.3795","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"1914_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5114\/ceh.2017.68466","volume":"3","author":"M Swiderska","year":"2017","unstructured":"Swiderska M, Jaroszewicz J, Stawicka A, Parfieniuk-Kowerda A, Chabowski A, Flisiak R (2017) The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease. Clin Exp Hepatol 3:127\u2013134. https:\/\/doi.org\/10.5114\/ceh.2017.68466","journal-title":"Clin Exp Hepatol"},{"key":"1914_CR24","doi-asserted-by":"publisher","first-page":"361847","DOI":"10.1155\/2015\/897914","volume":"2015","author":"K Xu","year":"2015","unstructured":"Xu K, Jiang M, Lu A, Gao X, Ghareeb DA, Khalil S, Hafez HS, Bajorath J, Ahmed HE, Sarhan E, Elwakeel E, El-Demellawy MA (2015) Berberine reduces neurotoxicity related to nonalcoholic steatohepatitis in rats. Evid Based Complement Alternat Med 2015:361847\u2013361849. https:\/\/doi.org\/10.1155\/2015\/897914","journal-title":"Evid Based Complement Alternat Med"},{"key":"1914_CR25","doi-asserted-by":"publisher","first-page":"e0134172","DOI":"10.1371\/journal.pone.0134172","volume":"10","author":"HM Yan","year":"2015","unstructured":"Yan HM, Xia MF, Wang Y, Chang XX, Yao XZ, Rao SX, Zeng MS, Tu YF, Feng R, Jia WP, Liu J, Deng W, Jiang JD, Gao X (2015) Efficacy of berberine in patients with non-alcoholic fatty liver disease. PLoS One 10:e0134172. https:\/\/doi.org\/10.1371\/journal.pone.0134172","journal-title":"PLoS One"},{"key":"1914_CR26","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.3892\/mmr.2016.5634","volume":"14","author":"W Yang","year":"2016","unstructured":"Yang W, She L, Yu K, Yan S, Zhang X, Tian X, Ma S, Zhang X (2016) Jatrorrhizine hydrochloride attenuates hyperlipidemia in a high-fat diet-induced obesity mouse model. Mol Med Rep 14:3277\u20133284. https:\/\/doi.org\/10.3892\/mmr.2016.5634","journal-title":"Mol Med Rep"},{"key":"1914_CR27","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.3892\/etm.2017.5051","volume":"14","author":"J Yang","year":"2017","unstructured":"Yang J, Ma XJ, Li L, Wang L, Chen YG, Liu J, Luo Y, Zhuang ZJ, Yang WJ, Zang SF, Shi JP (2017) Berberine ameliorates non-alcoholic steatohepatitis in ApoE(-\/-) mice. Exp Ther Med 14:4134\u20134140. https:\/\/doi.org\/10.3892\/etm.2017.5051","journal-title":"Exp Ther Med"},{"key":"1914_CR28","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.3892\/mmr.2017.7338","volume":"16","author":"F Ye","year":"2017","unstructured":"Ye F, Zhou Q, Tian L, Lei F, Feng D (2017) The protective effect of berberine hydrochloride on LPSinduced osteoclastogenesis through inhibiting TRAF6Ca2+calcineurinNFATcl signaling pathway. Mol Med Rep 16:6228\u20136233. https:\/\/doi.org\/10.3892\/mmr.2017.7338","journal-title":"Mol Med Rep"},{"key":"1914_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.intimp.2018.12.036","volume":"68","author":"L Zhu","year":"2019","unstructured":"Zhu L, Gu P, Shen H (2019) Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats. Int Immunopharmacol 68:242\u2013251. https:\/\/doi.org\/10.1016\/j.intimp.2018.12.036","journal-title":"Int Immunopharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01914-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-020-01914-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-020-01914-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T23:16:16Z","timestamp":1623280576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-020-01914-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1914"],"URL":"https:\/\/doi.org\/10.1007\/s00210-020-01914-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"18 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental protocols were established according to the Declaration of Helsinki. All animals used in this study complied with the ARRIVE guidelines and the protocols were approved by the institutional animal committee of Zhejiang Academy of Traditional Chinese Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}